Yuejun Chen
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: July 08, 2026
Survival benefit and dynamics of CD8+ T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study.
Journal: Frontiers in immunology
Published: January 15, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: November 04, 2025
Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management.
Journal: The Journal of thoracic and cardiovascular surgery
Published: November 04, 2025
LncRNA HCP5 remodels G6PD dual post-translational modification to mediate metabolic adaptations driving osimertinib resistance in lung adenocarcinoma.
Journal: Journal of advanced research
Published: August 30, 2025
microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma.
Journal: Genes
Published: February 02, 2023
Recent advances in immunoassay technologies for the detection of human coronavirus infections.
Journal: Frontiers in cellular and infection microbiology
Published: September 09, 2022
LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Journal: Anti-cancer drugs
Published: June 20, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026